Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MSU-42011 is an orally active retinoid X receptor-like (RXR) agonist.MSU-42011 potently inhibits the expression of iNOS, low SREBP-induced and activated RXR, and p-ERK at the protein level.MSU-42011 has demonstrated antitumor activity in a kras-driven mouse model of lung cancer.MSU-42011 is an effective therapy for the treatment of preclinical krasdriven lung cancer and has immunomodulatory activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 463.00 | |
100 mg | In stock | $ 747.00 | |
500 mg | In stock | $ 1,520.00 |
Description | MSU-42011 is an orally active retinoid X receptor-like (RXR) agonist.MSU-42011 potently inhibits the expression of iNOS, low SREBP-induced and activated RXR, and p-ERK at the protein level.MSU-42011 has demonstrated antitumor activity in a kras-driven mouse model of lung cancer.MSU-42011 is an effective therapy for the treatment of preclinical krasdriven lung cancer and has immunomodulatory activity. |
Targets&IC50 | iNOS:158 nM |
In vitro |
MSU-42011 (300 nM; 8 h) showed a low induction effect on SREBP in HepG2 cells.[1] MSU-42011 (0-5000 nM; 24 h) can activate RXR in HepG2 cells.[1] |
In vivo |
MSU-42011 (25 mg/kg; oral; for 12 weeks) significantly reduced the number, size, and overall tumor burden of tumors in the A/J mouse lung cancer model. Compared with the control group, there were fewer cells with active proliferation and showed a significant decrease in p-ERK [1]. MSU-42011 (25 mg/kg; oral; single dose) is most effective in reducing the number, size, and overall tumor burden of the A/J mouse lung cancer model in combination with C/P. Reduced macrophages in the lungs and increased activation markers of CD8+T cells [1]. MSU42011 (100 mg/kg; PO; single dose) reduces tumor burden in a mouse lung tumor model [2]. |
Molecular Weight | 382.54 |
Formula | C24H34N2O2 |
CAS No. | 2456434-36-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MSU-42011 2456434-36-7 Apoptosis Immunology/Inflammation Metabolism NO Synthase PERK Retinoid Receptor Lipid NOS MSU42011 6((3,5ditertbutylphenyl)(isobutyl)amino)nicotinicacid MSU 42011 inhibitor inhibit